Skip to main content
Livermore
Livermore
ZHEN

CymaBay Therapeutics, Inc.

CBAYDelisted Mar 22, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001042074

CymaBay Therapeutics, Inc. was delisted on Mar 22, 2024; its insiders filed their last Form 4 on Mar 22, 2024; 200 institutions reported holding it in 13F filings for Q4 2023, worth $2.71B in total; no superinvestor held it.

13F holders, Q1 2023

Institutional positions in CymaBay Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+23 vs. Q4 2022
Shares held
88.8M
+23.7M (+36.4%) vs. Q4 2022
Total value
$774.9M
+$371.5M (+92.1%) vs. Q4 2022
New holders
42
43 more added
Sold out
19
37 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CBAY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 140 institutions
Q1 2021: 130 institutionsQ2 2021: 113 institutionsQ3 2021: 114 institutionsQ4 2021: 113 institutionsQ1 2022: 118 institutionsQ2 2022: 106 institutionsQ3 2022: 100 institutionsQ4 2022: 118 institutionsQ1 2023: 140 institutionsQ2 2023: 151 institutionsQ3 2023: 189 institutionsQ4 2023: 200 institutionsQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2023: $774.9M
Q1 2021: $251.7MQ2 2021: $227.4MQ3 2021: $169.3MQ4 2021: $215.7MQ1 2022: $202.8MQ2 2022: $185.9MQ3 2022: $217.9MQ4 2022: $404.2MQ1 2023: $774.9MQ2 2023: $1.02BQ3 2023: $1.61BQ4 2023: $2.71BQ1 2024: $21.1KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CBAY and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$21.1K
Q4 2023200$2.71B
Q3 2023189$1.61B
Q2 2023151$1.02B
Q1 2023140$774.9M
Q4 2022118$404.2M
Q3 2022100$217.9M
Q2 2022106$185.9M
Q1 2022118$202.8M
Q4 2021113$215.7M
Q3 2021114$169.3M
Q2 2021113$227.4M
Q1 2021130$251.7M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding CymaBay Therapeutics, Inc.; share changes are against Q4 2022.

Institutions holding CBAY in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Point72 Middle East FZE19,618$171.1K0.01%+19,618New
Man Group plc–$158.9K0.00%––
Johnson Investment Counsel Inc18,000$157.0K0.00%00.0%Unchanged
Jefferies Financial Group Inc.17,899$156.1K0.00%+17,899New
Gsa Capital Partners LLP17,468$152.0K0.02%−48,861−73.7%Reduced
Boothbay Fund Management, LLC16,249$141.7K0.00%−1,822−10.1%Reduced
Strategic Blueprint, LLC15,800$137.8K0.01%−2,400−13.2%Reduced
Pictet Asset Management SA15,707$137.0K0.00%+15,707New
Zurcher Kantonalbank (Zurich Cantonalbank)15,149$132.1K0.00%+15,149New
Algert Global LLC15,080$131.5K0.01%−38,470−71.8%Reduced
Bank of Nova Scotia13,554$118.2K0.00%+13,554New
Profund Advisors LLC13,203$115.1K0.01%+13,203New
Lake Street Financial LLC12,900$112.5K0.02%00.0%Unchanged
FMR LLC11,254$98.1K0.00%+14+0.1%Added
Prelude Capital Management, LLC10,973$95.7K0.01%+10,973New
CTC Capital Management, LLC10,700$93.3K0.20%+10,700New
Lighthouse Investment Partners, LLC10,092$88.0K0.01%−30,001−74.8%Reduced
Victory Capital Management Inc10,077$87.9K0.00%+10,077New
Advisor Group Holdings, Inc.6,250$56.3K0.00%00.0%Unchanged
Dorsey Wright & Associates5,547$48.4K0.01%−615−10.0%Reduced
Great West Life Assurance Co4,602$40.0K0.00%+4,602New
Tower Research Capital LLC (TRC)1,828$16.0K0.00%−229−11.1%Reduced
Global Retirement Partners, LLC1,200$12.3K0.00%00.0%Unchanged
Truvestments Capital LLC1,364$11.9K0.01%−27−1.9%Reduced
China Universal Asset Management Co., Ltd.1,282$11.2K0.00%+422+49.1%Added
Nisa Investment Advisors, LLC1,150$10.0K0.00%00.0%Unchanged
IFP Advisors, Inc650$8.24K0.00%−1,000−60.6%Reduced
EverSource Wealth Advisors, LLC679$5.92K0.00%−634−48.3%Reduced
Wells Fargo & Company619$5.40K0.00%+82+15.3%Added
Steward Partners Investment Advisory, LLC500$4.36K0.00%00.0%Unchanged
US Bancorp360$3.14K0.00%+360New
Daiwa Securities Group Inc.341$3.00K0.00%00.0%Unchanged
TCI Wealth Advisors, Inc.341$2.97K0.00%+341New
Quadrant Capital Group LLC236$2.06K0.00%00.0%Unchanged
Creative Planning231$2.02K0.00%+231New
Activest Wealth Management69$6200.00%00.0%Unchanged
Parallel Advisors, LLC41$3580.00%+41New
Macroview Investment Management LLC1$90.00%00.0%Unchanged
Glassman Wealth Services1$90.00%00.0%Unchanged
Royal Bank of Canada26$00.00%−10,553−99.8%Reduced
Baker Bros. Advisors LP0$00.00%−2,170,464−100.0%Sold out
Sio Capital Management, LLC0$00.00%−555,610−100.0%Sold out
Walleye Capital LLC0$00.00%−488,894−100.0%Sold out
EAM Global Investors LLC0$00.00%−311,808−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−171,059−100.0%Sold out
CM Management, LLC0$00.00%−160,000−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−121,683−100.0%Sold out
Ergoteles LLC0$00.00%−103,997−100.0%Sold out
Conning Inc.0$00.00%−78,529−100.0%Sold out
Fosun International Ltd0$00.00%−78,529−100.0%Sold out
Cheyne Capital Management (UK) LLP0$00.00%−77,499−100.0%Sold out
Jump Financial, LLC0$00.00%−70,801−100.0%Sold out
Bank of Montreal0$00.00%−56,276−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−25,000−100.0%Sold out
Walleye Trading LLC0$00.00%−24,412−100.0%Sold out
Quantamental Technologies LLC0$00.00%−14,910−100.0%Sold out
Ameriprise Financial Inc0$00.00%−11,561−100.0%Sold out
Belvedere Trading LLC0$00.00%−4,695−100.0%Sold out
Signaturefd, LLC0$00.00%−116−100.0%Sold out
Abingworth LLP––––Not filed